Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Anacor Pharmaceuticals Inc    ANAC   US0324201013

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
02/25/2015 02/26/2015 02/27/2015 03/02/2015 03/03/2015 Date
43.57(c) 44.1(c) 43.5(c) 44.04(c) 43.57 Last
394 787 351 228 420 453 330 898 323 767 Volume
+1.51% +1.22% -1.36% +1.24% -1.07% Change
More quotes
Company
Anacor Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on discovering, developing and commercializing novel small-molecule therapeutics derived from its boron chemistry platform.The company has discovered seven compounds that are currently in development including its lead... 
Sector
Biotechnology & Medical Research
Calendar
03/03 | 08:00amPresentation
More about the company
Surperformance© ratings of Anacor Pharmaceuticals Inc
Trading Rating : Investor Rating :
More Ratings
Chart ANACOR PHARMACEUTICALS INC
Duration : Period :
Anacor Pharmaceuticals Inc Technical Analysis Chart | ANAC | US0324201013 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 15,8 M
EBIT 2014 -94,6 M
Net income 2014 -99,5 M
Debt 2014 25,7 M
Yield 2014 -
Sales 2015 41,6 M
EBIT 2015 -72,2 M
Net income 2015 -74,7 M
Debt 2015 61,3 M
Yield 2015 -
PER 2014 -
PER 2015
EV / Sales 2014 121x
EV / Sales 2015 46,9x
Capitalization 1 889 M
More Financials
Latest news on ANACOR PHARMACEUTICALS INC
02/25 ANACOR PHARMACEUTICALS : to Present at the 35th Annual Cowen Health Care Confere..
01/12 ANACOR PHARMACEUTICALS : Entry into a Material Definitive Agreement, Regulation ..
01/07 ANACOR PHARMACEUTICALS : Symbiota : Names Entrepreneurial Leader David P. Perry ..
2014 ANACOR PHARMACEUTICALS : Assigned Patent
2014 ANACOR PHARMACEUTICALS : U.S. Patents Awarded to Inventors in Pennsylvania (Nov...
2014 ANACOR PHARMACEUTICALS : U.S. Patents Awarded to Inventors in Ohio (Nov. 24)
2014 ANACOR PHARMACEUTICALS : Assigned Patent
2014 ANACOR PHARMACEUTICALS : to Take Part in the 2014 Credit Suisse Healthcare Confe..
More news
Sector news Biotechnology & Medical Research - NEC
11:36a ACTELION : New Drug Application for selexipag (Uptravi) is accepted by the US FD..
10:51a MEDIVATION : Tuesday 3/3 Insider Buying Report: MDVN, QSR
03/02 PUMA BIOTECHNOLOGY : Biotech reports 4Q loss
Plus d'actualités du secteur Biotechnology & Medical Research - NEC


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF